{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:32:56Z","timestamp":1783020776888,"version":"3.54.6"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,27]]},"DOI":"10.7759\/cureus.70335","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:06:09Z","timestamp":1727453169000},"source":"Crossref","is-referenced-by-count":7,"title":["Ocular Manifestations in Seborrheic Dermatitis Epidemiology, Clinical Features, and Management: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Rasha M","family":"Alofi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujain S","family":"Alrohaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada N","family":"Alharthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May M","family":"Almouteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.13188\/2373-1044.1000019","article-title":"Seborrheic dermatitis and dandruff: a comprehensive review (PREPRINT)","volume":"3","author":"Borda LJ","year":"2015","unstructured":"Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review (PREPRINT). J Clin Investig Dermatol. 2015, 3:10.13188\/2373-1044.1000019","journal-title":"J Clin Investig Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling G","year":"2011","unstructured":"Geerling G, Tauber J, Baudouin C, et al.. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011, 52:2050-64. 10.1167\/iovs.10-6997g","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/s0365-05962011000600002","article-title":"Seborrheic dermatitis","volume":"86","author":"Sampaio AL","year":"2011","unstructured":"Sampaio AL, Mameri AC, Vargas TJ, Ramos-e-Silva M, Nunes AP, Carneiro SC. Seborrheic dermatitis. An Bras Dermatol. 2011, 86:1061-71; quiz 1072-4. 10.1590\/s0365-05962011000600002","journal-title":"An Bras Dermatol"},{"key":"ref4","article-title":"Common dermatologic disorders in skin of color: a comparative practice survey","volume":"80","author":"Alexis AF","year":"2007","unstructured":"Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007, 80:387-94.","journal-title":"Cutis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.3.318","article-title":"The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap)","volume":"139","author":"Foley P","year":"2003","unstructured":"Foley P, Zuo Y, Plunkett A, Merlin K, Marks R. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol. 2003, 139:318-22. 10.1001\/archderm.139.3.318","journal-title":"Arch Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.01.001","article-title":"Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies","volume":"31","author":"Dessinioti C","year":"2013","unstructured":"Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013, 31:343-51. 10.1016\/j.clindermatol.2013.01.001","journal-title":"Clin Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00693.x","article-title":"Seborrheic dermatitis","volume":"18","author":"Gupta AK","year":"2004","unstructured":"Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatology Venereol. 2004, 18:13-26. 10.1111\/j.1468-3083.2004.00693.x","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1087-0024.2005.10104.x","article-title":"The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff","volume":"10","author":"Ro BI","year":"2005","unstructured":"Ro BI, Dawson TL. The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. J Investig Dermatol Symp Proc. 2005, 10:194-7. 10.1111\/j.1087-0024.2005.10104.x","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04082.x","article-title":"Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry","volume":"144","author":"Faergemann J","year":"2001","unstructured":"Faergemann J, Bergbrant IM, Dohs\u00e9 M, Scott A, Westgate G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol. 2001, 144:549-56. 10.1046\/j.1365-2133.2001.04082.x","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00004397-198502510-00010","article-title":"Blepharitis associated with acne rosacea and seborrheic dermatitis","volume":"25","author":"McCulley JP","year":"1985","unstructured":"McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. Int Ophthalmol Clin. 1985, 25:159-72. 10.1097\/00004397-198502510-00010","journal-title":"Int Ophthalmol Clin"},{"key":"ref11","unstructured":"Kanski\u2019s Clinical Ophthalmology - 9780702077111. Accessed. July 14, 2024. https:\/\/www.us.elsevierhealth.com\/kanskis-clinical-ophthalmology-9780702077111.html.."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.133.1.49","article-title":"Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline","volume":"133","author":"Quarterman MJ","year":"1997","unstructured":"Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, Davis LS. Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol. 1997, 133:49-54. 10.1001\/archderm.133.1.49","journal-title":"Arch Dermatol"},{"key":"ref13","article-title":"Ophthalmic manifestations of seborrheic dermatitis","volume":"21","author":"Singh A","year":"2023","unstructured":"Singh A, Kansal NK, Kumawat D, Samanta R, Agrawal A, Devi DA. Ophthalmic manifestations of seborrheic dermatitis. Skinmed. 2023, 21:397-401.","journal-title":"Skinmed"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-260","article-title":"A systematic review of musculoskeletal disorders among school teachers","volume":"12","author":"Erick PN","year":"2011","unstructured":"Erick PN, Smith DR. A systematic review of musculoskeletal disorders among school teachers. BMC Musculoskelet Disord. 2011, 12:260. 10.1186\/1471-2474-12-260","journal-title":"BMC Musculoskelet Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0232-2","article-title":"Topical treatment of facial seborrheic dermatitis: a systematic review","volume":"18","author":"Gupta AK","year":"2017","unstructured":"Gupta AK, Versteeg SG. Topical treatment of facial seborrheic dermatitis: a systematic review. Am J Clin Dermatol. 2017, 18:193-213. 10.1007\/s40257-016-0232-2","journal-title":"Am J Clin Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020151","article-title":"The antifungal and ocular permeation of ketoconazole from ophthalmic formulations containing trans-ethosomes nanoparticles","volume":"13","author":"Ahmed TA","year":"2021","unstructured":"Ahmed TA, Alzahrani MM, Sirwi A, Alhakamy NA. The antifungal and ocular permeation of ketoconazole from ophthalmic formulations containing trans-ethosomes nanoparticles. Pharmaceutics. 2021, 13:151. 10.3390\/pharmaceutics13020151","journal-title":"Pharmaceutics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/09546630802286993","article-title":"An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis","volume":"20","author":"Koc E","year":"2009","unstructured":"Koc E, Arca E, Kose O, Akar A. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. J Dermatolog Treat. 2009, 20:4-9. 10.1080\/09546630802286993","journal-title":"J Dermatolog Treat"},{"key":"ref18","article-title":"Dermatitis","author":"Mu\u00f1iz AE","year":"2007","unstructured":"Mu\u00f1iz AE. Dermatitis. Pediatric Emergency Medicine. Baren JM, Rothrock SG, Brennan JA, Brown LBT-PEM (ed): W.B. Saunders, Philadelphia, PA; 2007. 1016:978-141600087."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-35868-2.00076-1","article-title":"Seborrheic dermatitis","author":"Dattner AM","year":"2024","unstructured":"Dattner AM. Seborrheic dermatitis. Integr Med Fourth Ed (ed): StatPearls Publishing, Treasure Island, FL; 2024. 10.1016\/B978-0-323-35868-2.00076-1"},{"key":"ref20","article-title":"History of seborrheic dermatitis: conceptual and clinico-pathologic evolution","volume":"15","author":"Mameri ACA","year":"2017","unstructured":"Mameri ACA, Carneiro S, Mameri LMA, da Cunha JMT, Ramos-E-Silva M. History of seborrheic dermatitis: conceptual and clinico-pathologic evolution. Skinmed. 2017, 15:187-94.","journal-title":"Skinmed"},{"key":"ref21","unstructured":"Seborrheic dermatitis. Causes and treatment. (2024). Accessed: July 14, 2024: https:\/\/dermnetnz.org\/topics\/seborrhoeic-dermatitis."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14006","article-title":"Seborrheic dermatitis-looking beyond Malassezia","volume":"28","author":"Wikramanayake TC","year":"2019","unstructured":"Wikramanayake TC, Borda LJ, Miteva M, Paus R. Seborrheic dermatitis-looking beyond Malassezia. Exp Dermatol. 2019, 28:991-1001. 10.1111\/exd.14006","journal-title":"Exp Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2010.09.005","article-title":"Robert Willan: pioneer in morphology","volume":"29","author":"Grzybowski A","year":"2011","unstructured":"Grzybowski A, Parish LC. Robert Willan: pioneer in morphology. Clin Dermatol. 2011, 29:125-9. 10.1016\/j.clindermatol.2010.09.005","journal-title":"Clin Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/OPTO.S84795","article-title":"Diagnosis and management of blepharitis: an optometrist's perspective","volume":"8","author":"Putnam CM","year":"2016","unstructured":"Putnam CM. Diagnosis and management of blepharitis: an optometrist's perspective. Clin Optom (Auckl). 2016, 8:71-8. 10.2147\/OPTO.S84795","journal-title":"Clin Optom (Auckl)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-35951-4_932-1","article-title":"Seborrheic blepharitis","volume":"23","author":"Eltis M","year":"2012","unstructured":"Eltis M. Seborrheic blepharitis. Clin Refract Optom. 2012, 23:74-7. 10.1007\/978-3-642-35951-4_932-1","journal-title":"Clin Refract Optom"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-53808-2_54","article-title":"The Skin and the Eyes","author":"Tiwary AK","year":"2021","unstructured":"Tiwary AK, Kumar P, Roychoudhury S, Das A, Datta A, Hegde RS. The Skin and the Eyes. Smoller B, Bagherani N (ed): Springer International Publishing, Cham; 2021. 10.1007\/978-3-319-53808-2_54"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S284671","article-title":"An overview of the diagnosis and management of seborrheic dermatitis","volume":"15","author":"Dall'Oglio F","year":"2022","unstructured":"Dall'Oglio F, Nasca MR, Gerbino C, Micali G. An overview of the diagnosis and management of seborrheic dermatitis. Clin Cosmet Investig Dermatol. 2022, 15:1537-48. 10.2147\/CCID.S284671","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13030710","article-title":"Uncommon blepharitis","volume":"13","author":"Di Zazzo A","year":"2024","unstructured":"Di Zazzo A, Giannaccare G, Villani E, Barabino S. Uncommon blepharitis. J Clin Med. 2024, 13:710. 10.3390\/jcm13030710","journal-title":"J Clin Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1203a113","article-title":"Facial dermatoses in patients with Blepharitis: a cross-sectional prospective analysis","volume":"12","author":"G\u00fcder S","year":"2022","unstructured":"G\u00fcder S, \u00c7ulfa \u015e. Facial dermatoses in patients with Blepharitis: a cross-sectional prospective analysis. Dermatol Pract Concept. 2022, 12:e2022113. 10.5826\/dpc.1203a113","journal-title":"Dermatol Pract Concept"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/1179172117721902","article-title":"Ophthalmology in North America: early stories (1491-1801)","volume":"9","author":"Leffler CT","year":"2017","unstructured":"Leffler CT, Schwartz SG, Wainsztein RD, Pflugrath A, Peterson E. Ophthalmology in North America: early stories (1491-1801). Ophthalmol Eye Dis. 2017, 9:1179172117721902. 10.1177\/1179172117721902","journal-title":"Ophthalmol Eye Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1473554","article-title":"Treatment of seborrheic dermatitis: a comprehensive review","volume":"30","author":"Borda LJ","year":"2019","unstructured":"Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatolog Treat. 2019, 30:158-69. 10.1080\/09546634.2018.1473554","journal-title":"J Dermatolog Treat"},{"key":"ref32","article-title":"Seborrheic dermatitis: an overview","volume":"74","author":"Schwartz RA","year":"2006","unstructured":"Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006, 74:125-30.","journal-title":"Am Fam Physician"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-022-00930-5","article-title":"Seborrheic dermatitis in older adults: pathogenesis and treatment options","volume":"39","author":"Sowell J","year":"2022","unstructured":"Sowell J, Pena SM, Elewski BE. Seborrheic dermatitis in older adults: pathogenesis and treatment options. Drugs Aging. 2022, 39:315-21. 10.1007\/s40266-022-00930-5","journal-title":"Drugs Aging"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.614446","article-title":"Cutaneous Malassezia: commensal, pathogen, or protector?","volume":"10","author":"Vijaya Chandra SH","year":"2020","unstructured":"Vijaya Chandra SH, Srinivas R, Dawson TL Jr, Common JE. Cutaneous Malassezia: commensal, pathogen, or protector?. Front Cell Infect Microbiol. 2020, 10:614446. 10.3389\/fcimb.2020.614446","journal-title":"Front Cell Infect Microbiol"},{"key":"ref35","article-title":"Seborrheic dermatitis","volume":"52","author":"Janniger CK","year":"1995","unstructured":"Janniger CK, Schwartz RA. Seborrheic dermatitis. Am Fam Physician. 1995, 52:149-55.","journal-title":"Am Fam Physician"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00021-11","article-title":"The Malassezia genus in skin and systemic diseases","volume":"25","author":"Gaitanis G","year":"2012","unstructured":"Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012, 25:106-41. 10.1128\/CMR.00021-11","journal-title":"Clin Microbiol Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01169-21","article-title":"Presence of Malassezia hyphae is correlated with pathogenesis of seborrheic dermatitis","volume":"10","author":"Li J","year":"2022","unstructured":"Li J, Feng Y, Liu C, et al.. Presence of Malassezia hyphae is correlated with pathogenesis of seborrheic dermatitis. Microbiol Spectr. 2022, 10:e0116921. 10.1128\/spectrum.01169-21","journal-title":"Microbiol Spectr"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48782","article-title":"Association between diet and seborrheic dermatitis: a case-control study","volume":"15","author":"Alshaebi M","year":"2023","unstructured":"Alshaebi M, Zahed L, Osaylan M, Sulaimani S, Albahlool A, Abduljabbar MH, Hariri J. Association between diet and seborrheic dermatitis: a case-control study. Cureus. 2023, 15:e48782. 10.7759\/cureus.48782","journal-title":"Cureus"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.07.027","article-title":"Association between diet and seborrheic dermatitis: a cross-sectional study","volume":"139","author":"Sanders MG","year":"2019","unstructured":"Sanders MG, Pardo LM, Ginger RS, Kiefte-de Jong JC, Nijsten T. Association between diet and seborrheic dermatitis: a cross-sectional study. J Invest Dermatol. 2019, 139:108-14. 10.1016\/j.jid.2018.07.027","journal-title":"J Invest Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/19381980.2017.1375636","article-title":"Sebaceous-immunobiology is orchestrated by sebum lipids","volume":"9","author":"Lov\u00e1szi M","year":"2017","unstructured":"Lov\u00e1szi M, Szegedi A, Zouboulis CC, T\u00f6r\u0151csik D. Sebaceous-immunobiology is orchestrated by sebum lipids. Dermatoendocrinol. 2017, 9:e1375636. 10.1080\/19381980.2017.1375636","journal-title":"Dermatoendocrinol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4161\/derm.1.2.8472","article-title":"Sebaceous gland lipids","volume":"1","author":"Picardo M","year":"2009","unstructured":"Picardo M, Ottaviani M, Camera E, Mastrofrancesco A. Sebaceous gland lipids. Dermatoendocrinol. 2009, 1:68-71. 10.4161\/derm.1.2.8472","journal-title":"Dermatoendocrinol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15908","article-title":"Prevalence and determinants of seborrhoeic dermatitis in a middle-aged and elderly population: the Rotterdam Study","volume":"178","author":"Sanders MG","year":"2018","unstructured":"Sanders MG, Pardo LM, Franco OH, Ginger RS, Nijsten T. Prevalence and determinants of seborrhoeic dermatitis in a middle-aged and elderly population: the Rotterdam Study. Br J Dermatol. 2018, 178:148-53. 10.1111\/bjd.15908","journal-title":"Br J Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14091","article-title":"An update on the microbiology, immunology and genetics of seborrheic dermatitis","volume":"29","author":"Adalsteinsson JA","year":"2020","unstructured":"Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020, 29:481-9. 10.1111\/exd.14091","journal-title":"Exp Dermatol"},{"key":"ref44","article-title":"Adult seborrheic dermatitis: a status report on practical topical management","volume":"4","author":"Del Rosso JQ","year":"2011","unstructured":"Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol. 2011, 4:32-8.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15957","article-title":"A newer approach in the treatment of seborrheic dermatitis with QR678\u00ae and QR678 Neo\u00ae-A prospective pilot study","volume":"22","author":"Kapoor R","year":"2023","unstructured":"Kapoor R, Shome D, Doshi K, Patel G, Tandel H, Kumar V. A newer approach in the treatment of seborrheic dermatitis with QR678\u00ae and QR678 Neo\u00ae-A prospective pilot study. J Cosmet Dermatol. 2023, 22:3078-87. 10.1111\/jocd.15957","journal-title":"J Cosmet Dermatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02900-w","article-title":"Epidemiology of seborrheic dermatitis among adults in the United States: a cross-sectional analysis","volume":"316","author":"Haq Z","year":"2024","unstructured":"Haq Z, Abdi P, Wan V, et al.. Epidemiology of seborrheic dermatitis among adults in the United States: a cross-sectional analysis. Arch Dermatol Res. 2024, 316:394. 10.1007\/s00403-024-02900-w","journal-title":"Arch Dermatol Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.02.014","article-title":"No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins","volume":"88","author":"Mu\u00f1oz P","year":"2017","unstructured":"Mu\u00f1oz P, Vena A, Padilla B, et al.. No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins. Diagn Microbiol Infect Dis. 2017, 88:141-4. 10.1016\/j.diagmicrobio.2017.02.014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(82)34722-3","article-title":"Endogenous endophthalmitis among patients with candidemia","volume":"89","author":"Parke DW","year":"1982","unstructured":"Parke DW, Jones DB, Gentry LO. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982, 89:789-96. 10.1016\/S0161-6420(82)34722-3","journal-title":"Ophthalmology"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2021.104272","article-title":"Ocular manifestations of skin diseases with pathological keratinization abnormalities","volume":"38","author":"Zdebik A","year":"2021","unstructured":"Zdebik A, Zdebik N, Fischer M. Ocular manifestations of skin diseases with pathological keratinization abnormalities. Postepy Dermatol Alergol. 2021, 38:14-20. 10.5114\/ada.2021.104272","journal-title":"Postepy Dermatol Alergol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2019.03.005","article-title":"Evaluation of dry eye disase and meibomian gland dysfunction with meibography in seborrheic dermatitis","volume":"42","author":"Yasar E","year":"2019","unstructured":"Yasar E, Kemeriz F, Gurlevik U. Evaluation of dry eye disase and meibomian gland dysfunction with meibography in seborrheic dermatitis. Cont Lens Anterior Eye. 2019, 42:675-8. 10.1016\/j.clae.2019.03.005","journal-title":"Cont Lens Anterior Eye"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2014.05.005","article-title":"Treatment of blepharitis: recent clinical trials","volume":"12","author":"Pflugfelder SC","year":"2014","unstructured":"Pflugfelder SC, Karpecki PM, Perez VL. Treatment of blepharitis: recent clinical trials. Ocul Surf. 2014, 12:273-84. 10.1016\/j.jtos.2014.05.005","journal-title":"Ocul Surf"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3129\/I08-016","article-title":"Blepharitis: current strategies for diagnosis and management","volume":"43","author":"Jackson WB","year":"2008","unstructured":"Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol. 2008, 43:170-9. 10.3129\/I08-016","journal-title":"Can J Ophthalmol"},{"key":"ref53","article-title":"Seborrhea","volume":"39","author":"Shubaki A","year":"2005","unstructured":"Shubaki A, Al-ziyoud I, Al-madani M V, Jordan A. Seborrhea. Ocular Skin Involvement. 2005, 39:38-40.","journal-title":"Ocular Skin Involvement"},{"key":"ref54","article-title":"Optimizing treatment approaches in seborrheic dermatitis","volume":"6","author":"Gary G","year":"2013","unstructured":"Gary G. Optimizing treatment approaches in seborrheic dermatitis. J Clin Aesthet Dermatol. 2013, 6:44-9.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s00449-020-02333-5","article-title":"Malassezia and Staphylococcus dominate scalp microbiome for seborrheic dermatitis","volume":"44","author":"Lin Q","year":"2021","unstructured":"Lin Q, Panchamukhi A, Li P, Shan W, Zhou H, Hou L, Chen W. Malassezia and Staphylococcus dominate scalp microbiome for seborrheic dermatitis. Bioprocess Biosyst Eng. 2021, 44:965-75. 10.1007\/s00449-020-02333-5","journal-title":"Bioprocess Biosyst Eng"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02830-7","article-title":"More yeast, more problems?: reevaluating the role of Malassezia in seborrheic dermatitis","volume":"316","author":"Chang CH","year":"2024","unstructured":"Chang CH, Chovatiya R. More yeast, more problems?: reevaluating the role of Malassezia in seborrheic dermatitis. Arch Dermatol Res. 2024, 316:100. 10.1007\/s00403-024-02830-7","journal-title":"Arch Dermatol Res"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.834135","article-title":"The human skin microbiome in selected cutaneous diseases","volume":"12","author":"Carmona-Cruz S","year":"2022","unstructured":"Carmona-Cruz S, Orozco-Covarrubias L, S\u00e1ez-de-Ocariz M. The human skin microbiome in selected cutaneous diseases. Front Cell Infect Microbiol. 2022, 12:834135. 10.3389\/fcimb.2022.834135","journal-title":"Front Cell Infect Microbiol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.1.21-57.2002","article-title":"Immunology of diseases associated with Malassezia species","volume":"15","author":"Ashbee HR","year":"2002","unstructured":"Ashbee HR, Evans EG. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev. 2002, 15:21-57. 10.1128\/CMR.15.1.21-57.2002","journal-title":"Clin Microbiol Rev"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14127","article-title":"Ocular surface disease is common in moderate-to-severe atopic dermatitis patients","volume":"52","author":"Achten RE","year":"2022","unstructured":"Achten RE, Bakker DS, van Luijk CM, et al.. Ocular surface disease is common in moderate-to-severe atopic dermatitis patients. Clin Exp Allergy. 2022, 52:801-5. 10.1111\/cea.14127","journal-title":"Clin Exp Allergy"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-9922","article-title":"Comparative ocular microbial communities in humans with and without blepharitis","volume":"53","author":"Lee SH","year":"2012","unstructured":"Lee SH, Oh DH, Jung JY, Kim JC, Jeon CO. Comparative ocular microbial communities in humans with and without blepharitis. Invest Ophthalmol Vis Sci. 2012, 53:5585-93. 10.1167\/iovs.12-9922","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01798.x","article-title":"Impression cytology and ocular surface characteristics in patients with seborrhoeic dermatitis","volume":"89","author":"Karalezli A","year":"2011","unstructured":"Karalezli A, Borazan M, Dursun R, Kiyici H, Kucukerdonmez C, Akova YA. Impression cytology and ocular surface characteristics in patients with seborrhoeic dermatitis. Acta Ophthalmol. 2011, 89:e137-41. 10.1111\/j.1755-3768.2009.01798.x","journal-title":"Acta Ophthalmol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsymp.5650049","article-title":"Malassezia globosa and restricta: breakthrough understanding of the etiology and treatment of dandruff and seborrheic dermatitis through whole-genome analysis","volume":"12","author":"Dawson TL Jr","year":"2007","unstructured":"Dawson TL Jr. Malassezia globosa and restricta: breakthrough understanding of the etiology and treatment of dandruff and seborrheic dermatitis through whole-genome analysis. J Investig Dermatol Symp Proc. 2007, 12:15-9. 10.1038\/sj.jidsymp.5650049","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1080\/08164622.2021.1962210","article-title":"Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease","volume":"105","author":"Lee Y","year":"2022","unstructured":"Lee Y, Kim M, Galor A. Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease. Clin Exp Optom. 2022, 105:177-85. 10.1080\/08164622.2021.1962210","journal-title":"Clin Exp Optom"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1159\/000076478","article-title":"Etiology and management of seborrheic dermatitis","volume":"208","author":"Gupta AK","year":"2004","unstructured":"Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004, 208:89-93. 10.1159\/000076478","journal-title":"Dermatology"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2535_20","article-title":"Prevalence and risk factor assessment of digital eye strain among children using online e-learning during the COVID-19 pandemic: digital eye strain among kids (DESK study-1)","volume":"69","author":"Mohan A","year":"2021","unstructured":"Mohan A, Sen P, Shah C, Jain E, Jain S. Prevalence and risk factor assessment of digital eye strain among children using online e-learning during the COVID-19 pandemic: digital eye strain among kids (DESK study-1). Indian J Ophthalmol. 2021, 69:140-4. 10.4103\/ijo.IJO_2535_20","journal-title":"Indian J Ophthalmol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.12.007","article-title":"Sleep disturbances and atopic dermatitis: relationships, methods for assessment, and therapies","volume":"9","author":"Bawany F","year":"2021","unstructured":"Bawany F, Northcott CA, Beck LA, Pigeon WR. Sleep disturbances and atopic dermatitis: relationships, methods for assessment, and therapies. J Allergy Clin Immunol Pract. 2021, 9:1488-500. 10.1016\/j.jaip.2020.12.007","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.06.064","article-title":"Improving awareness, identification, and management of meibomian gland dysfunction","volume":"119","author":"Foulks GN","year":"2012","unstructured":"Foulks GN, Nichols KK, Bron AJ, Holland EJ, McDonald MB, Nelson JD. Improving awareness, identification, and management of meibomian gland dysfunction. Ophthalmology. 2012, 119:S1-12. 10.1016\/j.ophtha.2012.06.064","journal-title":"Ophthalmology"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67888-5","article-title":"Clinical efficacy of eyelid hygiene in blepharitis and meibomian gland dysfunction after cataract surgery: a randomized controlled pilot trial","volume":"10","author":"Eom Y","year":"2020","unstructured":"Eom Y, Na KS, Hwang HS, et al.. Clinical efficacy of eyelid hygiene in blepharitis and meibomian gland dysfunction after cataract surgery: a randomized controlled pilot trial. Sci Rep. 2020, 10:11796. 10.1038\/s41598-020-67888-5","journal-title":"Sci Rep"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16818","article-title":"An infant with seborrhoeic dermatitis and eczema herpeticum complicated by a generalized infection","volume":"13","author":"Karpierz K","year":"2021","unstructured":"Karpierz K, Kuchar EP. An infant with seborrhoeic dermatitis and eczema herpeticum complicated by a generalized infection. Cureus. 2021, 13:e16818. 10.7759\/cureus.16818","journal-title":"Cureus"},{"key":"ref70","article-title":"Seborrheic dermatitis in skin of color: clinical considerations","volume":"18","author":"Elgash M","year":"2019","unstructured":"Elgash M, Dlova N, Ogunleye T, Taylor SC. Seborrheic dermatitis in skin of color: clinical considerations. J Drugs Dermatol. 2019, 18:24-7.","journal-title":"J Drugs Dermatol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.13188\/2373-1044.1000086","article-title":"Uncommon petaloid form of seborrheic dermatitis seen in Fitzpatrick skin types V-VI","volume":"11","author":"Wu T","year":"2023","unstructured":"Wu T, Frommeyer TC, Rohan CA, Travers JB. Uncommon petaloid form of seborrheic dermatitis seen in Fitzpatrick skin types V-VI. J Clin Investig Dermatol. 2023, 11:10.13188\/2373-1044.1000086","journal-title":"J Clin Investig Dermatol"},{"key":"ref72","article-title":"Seborrheic dermatitis. An update","volume":"65","author":"Moreno-V\u00e1zquez K","year":"2021","unstructured":"Moreno-V\u00e1zquez K, Calder\u00f3n L, Bonifaz A. Seborrheic dermatitis. An update. Dermatologia Rev Mex. 2021, 65:39-49.","journal-title":"Dermatologia Rev Mex"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i1.92","article-title":"Ocular complications of diabetes mellitus","volume":"6","author":"Sayin N","year":"2015","unstructured":"Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015, 6:92-108. 10.4239\/wjd.v6.i1.92","journal-title":"World J Diabetes"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(03)00028-7","article-title":"Seborrheic dermatitis","volume":"21","author":"Gupta AK","year":"2003","unstructured":"Gupta AK, Bluhm R, Cooper EA, Summerbell RC, Batra R. Seborrheic dermatitis. Dermatol Clin. 2003, 21:401-12. 10.1016\/S0733-8635(03)00028-7","journal-title":"Dermatol Clin"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.58471","article-title":"Current approach in the diagnosis and management of panuveitis","volume":"58","author":"Bansal R","year":"2010","unstructured":"Bansal R, Gupta V, Gupta A. Current approach in the diagnosis and management of panuveitis. Indian J Ophthalmol. 2010, 58:45-54. 10.4103\/0301-4738.58471","journal-title":"Indian J Ophthalmol"},{"key":"ref76","article-title":"Safe and effective treatment of seborrheic dermatitis","volume":"83","author":"Elewski BE","year":"2009","unstructured":"Elewski BE. Safe and effective treatment of seborrheic dermatitis. Cutis. 2009, 83:333-8.","journal-title":"Cutis"},{"key":"ref77","article-title":"Seborrheic dermatitis of the scalp: etiology and treatment","volume":"3","author":"Gupta AK","year":"2004","unstructured":"Gupta AK, Nicol KA. Seborrheic dermatitis of the scalp: etiology and treatment. J Drugs Dermatol. 2004, 3:155-8.","journal-title":"J Drugs Dermatol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1097\/01.NPR.0000399717.56736.1e","article-title":"Seborrheic dermatitis: a clinical practice snapshot","volume":"36","author":"Schmidt JA","year":"2011","unstructured":"Schmidt JA. Seborrheic dermatitis: a clinical practice snapshot. Nurse Pract. 2011, 36:32-7. 10.1097\/01.NPR.0000399717.56736.1e","journal-title":"Nurse Pract"},{"key":"ref79","article-title":"Approach to treating seborrheic dermatitis in skin of color","volume":"17","author":"Sangha AM","year":"2024","unstructured":"Sangha AM. Approach to treating seborrheic dermatitis in skin of color. J Clin Aesthet Dermatol. 2024, 17:22-3.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.5603\/fd.a2023.0010","article-title":"Infantile seborrheic dermatitis differential diagnosis based on case report","volume":"9","author":"Bie\u0144 N","year":"2023","unstructured":"Bie\u0144 N, Rajczak M, Lipi\u0144ska K, Narbutt J, Skibi\u0144ska M, Lesiak A. Infantile seborrheic dermatitis differential diagnosis based on case report. Forum Dermatologicum. 2023, 9:123-5. 10.5603\/fd.a2023.0010","journal-title":"Forum Dermatologicum"},{"key":"ref81","article-title":"Dry Eye Syndrome","author":"Golden MI","year":"2024","unstructured":"Golden MI, Meyer JJ, Zeppieri M, Patel BC. Dry Eye Syndrome. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005556.pub2","article-title":"Interventions for chronic blepharitis","volume":"2012","author":"Lindsley K","year":"2012","unstructured":"Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012, 2012:CD005556. 10.1002\/14651858.CD005556.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3629","article-title":"Management of ocular manifestations of atopic dermatitis: a consensus meeting using a modified Delphi process","volume":"100","author":"Thyssen JP","year":"2020","unstructured":"Thyssen JP, Heegaard S, Ivert L, et al.. Management of ocular manifestations of atopic dermatitis: a consensus meeting using a modified Delphi process. Acta Derm Venereol. 2020, 100:adv00264. 10.2340\/00015555-3629","journal-title":"Acta Derm Venereol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11131911","article-title":"Advancing dermatological care: a comprehensive narrative review of tele-dermatology and mHealth for bridging gaps and expanding opportunities beyond the COVID-19 pandemic","volume":"11","author":"Giansanti D","year":"2023","unstructured":"Giansanti D. Advancing dermatological care: a comprehensive narrative review of tele-dermatology and mHealth for bridging gaps and expanding opportunities beyond the COVID-19 pandemic. Healthcare (Basel). 2023, 11:1911. 10.3390\/healthcare11131911","journal-title":"Healthcare (Basel)"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.2478\/arsm-2022-0037","article-title":"Impact of seborrheic dermatitis manifestations on quality of life during COVID-19 pandemic","volume":"28","author":"Apetri RC","year":"2022","unstructured":"Apetri RC, Gurgas L. Impact of seborrheic dermatitis manifestations on quality of life during COVID-19 pandemic. ARS Medica Tomitana. 2022, 28:176-9. 10.2478\/arsm-2022-0037","journal-title":"ARS Medica Tomitana"},{"key":"ref86","doi-asserted-by":"crossref","DOI":"10.31655\/2307-3373-2022-1-2-59-72","article-title":"Atopic dermatitis: differential diagnosis (Part 2)","volume":"2022","author":"\u041ekhotnikova \u0415N","year":"2022","unstructured":"\u041ekhotnikova \u0415N, Duda L, Yakovleva NY. Atopic dermatitis: differential diagnosis (Part 2). Asthma Allergy. 2022, 2022:59-72.","journal-title":"Asthma Allergy"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.12.017","article-title":"Unmet needs for patients with seborrheic dermatitis","volume":"90","author":"Jackson JM","year":"2024","unstructured":"Jackson JM, Alexis A, Zirwas M, Taylor S. Unmet needs for patients with seborrheic dermatitis. J Am Acad Dermatol. 2024, 90:597-604. 10.1016\/j.jaad.2022.12.017","journal-title":"J Am Acad Dermatol"},{"key":"ref88","article-title":"Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis","volume":"6","author":"Kim GK","year":"2013","unstructured":"Kim GK, Del RJ. Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis. J Clin Aesthet Dermatol. 2013, 6:29-35.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1382","article-title":"A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health","volume":"93","author":"Schwartz JR","year":"2013","unstructured":"Schwartz JR, Messenger AG, Tosti A, et al.. A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health. Acta Derm Venereol. 2013, 93:131-7. 10.2340\/00015555-1382","journal-title":"Acta Derm Venereol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1159\/000512786","article-title":"The impact of shampoo wash frequency on scalp and hair conditions","volume":"7","author":"Punyani S","year":"2021","unstructured":"Punyani S, Tosti A, Hordinsky M, Yeomans D, Schwartz J. The impact of shampoo wash frequency on scalp and hair conditions. Skin Appendage Disord. 2021, 7:183-93. 10.1159\/000512786","journal-title":"Skin Appendage Disord"},{"key":"ref91","article-title":"Seborrheic Dermatitis","author":"Tucker D","year":"2024","unstructured":"Tucker D, Masood S. Seborrheic Dermatitis. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2019.100433","article-title":"How does mental health stigma get under the skin? Cross-sectional analysis using the Health Survey for England","volume":"8","author":"Niedzwiedz CL","year":"2019","unstructured":"Niedzwiedz CL. How does mental health stigma get under the skin? Cross-sectional analysis using the Health Survey for England. SSM Popul Health. 2019, 8:100433. 10.1016\/j.ssmph.2019.100433","journal-title":"SSM Popul Health"},{"key":"ref93","article-title":"Relapse prevention in schizophrenia - new therapeutic challenges","volume":"19","author":"Ku\u01d4kali\u0107 A","year":"2007","unstructured":"Ku\u01d4kali\u0107 A, D\u017eubur-Kulenovi\u0107 A, Mehmedika-Sulji\u0107 E. Relapse prevention in schizophrenia - new therapeutic challenges. Psychiatr Danub. 2007, 19:362-6.","journal-title":"Psychiatr Danub"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.4103\/0975-7406.100277","article-title":"Clinical and pharmacological management of endodontic flare-up","volume":"4","author":"Jayakodi H","year":"2012","unstructured":"Jayakodi H, Kailasam S, Kumaravadivel K, Thangavelu B, Mathew S. Clinical and pharmacological management of endodontic flare-up. J Pharm Bioallied Sci. 2012, 4:S294-8. 10.4103\/0975-7406.100277","journal-title":"J Pharm Bioallied Sci"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-013-0019-7","article-title":"Psychiatric comorbidities and alexithymia in patients with seborrheic dermatitis: a questionnaire study in Turkey","volume":"14","author":"C\u00f6mert A","year":"2013","unstructured":"C\u00f6mert A, Akba\u015f B, K\u0131l\u0131\u00e7 EZ, Ak\u0131n \u00d6, G\u00f6k\u00e7e E, G\u00f6ktuna Z, Ta\u015fkapan O. Psychiatric comorbidities and alexithymia in patients with seborrheic dermatitis: a questionnaire study in Turkey. Am J Clin Dermatol. 2013, 14:335-42. 10.1007\/s40257-013-0019-7","journal-title":"Am J Clin Dermatol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2021.67503","article-title":"Is the frequency of seborrheic dermatitis related to climate parameters?","volume":"56","author":"Akbulut TO","year":"2022","unstructured":"Akbulut TO, Suslu H, Atci T. Is the frequency of seborrheic dermatitis related to climate parameters?. Sisli Etfal Hastan Tip Bul. 2022, 56:91-5. 10.14744\/SEMB.2021.67503","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03801-y","article-title":"Effect of ocular demodicosis on the stability of the tear film and the tear break up time","volume":"11","author":"S\u0119dzikowska A","year":"2021","unstructured":"S\u0119dzikowska A, Tarkowski W, Moneta-Wielgo\u015b J, Grzyli\u0144ski K, Tarkowski G, M\u0142ocicki D. Effect of ocular demodicosis on the stability of the tear film and the tear break up time. Sci Rep. 2021, 11:24296. 10.1038\/s41598-021-03801-y","journal-title":"Sci Rep"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.30773\/pi.2019.0193","article-title":"Skin diseases in patients with primary psychiatric disorders","volume":"17","author":"Mavrogiorgou P","year":"2020","unstructured":"Mavrogiorgou P, Mersmann C, Gerlach G, Herpertz S, Juckel G. Skin diseases in patients with primary psychiatric disorders. Psychiatry Investig. 2020, 17:157-62. 10.30773\/pi.2019.0193","journal-title":"Psychiatry Investig"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011380.pub2","article-title":"Interventions for infantile seborrhoeic dermatitis (including cradle cap)","volume":"3","author":"Victoire A","year":"2019","unstructured":"Victoire A, Magin P, Coughlan J, van Driel ML. Interventions for infantile seborrhoeic dermatitis (including cradle cap). Cochrane Database Syst Rev. 2019, 3:CD011380. 10.1002\/14651858.CD011380.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref100","article-title":"Treatment of seborrheic dermatitis","volume":"61","author":"Johnson BA","year":"2000","unstructured":"Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Am Fam Physician. 2000, 61:2703-10.","journal-title":"Am Fam Physician"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200308000-00011","article-title":"Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis","volume":"22","author":"Ta CN","year":"2003","unstructured":"Ta CN, Shine WE, McCulley JP, Pandya A, Trattler W, Norbury JW. Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis. Cornea. 2003, 22:545-8. 10.1097\/00003226-200308000-00011","journal-title":"Cornea"},{"key":"ref102","article-title":"Medicated shampoos for the treatment of seborrheic dermatitis","volume":"7","author":"Waldroup W","year":"2008","unstructured":"Waldroup W, Scheinfeld N. Medicated shampoos for the treatment of seborrheic dermatitis. J Drugs Dermatol. 2008, 7:699-703.","journal-title":"J Drugs Dermatol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2008.01624.x","article-title":"Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level","volume":"52","author":"Szepietowski JC","year":"2009","unstructured":"Szepietowski JC, Reich A, Weso\u0142owska-Szepietowska E, Baran E. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses. 2009, 52:357-63. 10.1111\/j.1439-0507.2008.01624.x","journal-title":"Mycoses"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2023.01.023","article-title":"Seborrheic dermatitis: topical therapeutics and formulation design","volume":"185","author":"Mangion SE","year":"2023","unstructured":"Mangion SE, Mackenzie L, Roberts MS, Holmes AM. Seborrheic dermatitis: topical therapeutics and formulation design. Eur J Pharm Biopharm. 2023, 185:148-64. 10.1016\/j.ejpb.2023.01.023","journal-title":"Eur J Pharm Biopharm"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.14744\/bej.2021.62533","article-title":"The effect of chalazion excision on corneal aberrometric and densitometric values","volume":"6","author":"Oncul H","year":"2021","unstructured":"Oncul H, Yildirim Y, Caglayan M, Dag U, Alakus MF. The effect of chalazion excision on corneal aberrometric and densitometric values. Beyoglu Eye J. 2021, 6:191-9. 10.14744\/bej.2021.62533","journal-title":"Beyoglu Eye J"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0388","article-title":"Seborrheic Dermatitis","volume":"108","author":"Heath CR","year":"2021","unstructured":"Heath CR, Usatine RP. Seborrheic Dermatitis. Cutis. 2021, 108:297-8. 10.12788\/cutis.0388","journal-title":"Cutis"},{"key":"ref107","article-title":"Malassezia species and seborrheic dermatitis","volume":"51","author":"Zisova LG","year":"2009","unstructured":"Zisova LG. Malassezia species and seborrheic dermatitis. Folia Med (Plovdiv). 2009, 51:23-33.","journal-title":"Folia Med (Plovdiv)"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14952","article-title":"Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition","volume":"33","author":"Rousel J","year":"2024","unstructured":"Rousel J, N\u0103d\u0103ban A, Saghari M, et al.. Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition. Exp Dermatol. 2024, 33:e14952. 10.1111\/exd.14952","journal-title":"Exp Dermatol"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01558-y","article-title":"Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China","volume":"18","author":"Xuan M","year":"2020","unstructured":"Xuan M, Lu C, He Z. Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China. Health Qual Life Outcomes. 2020, 18:308. 10.1186\/s12955-020-01558-y","journal-title":"Health Qual Life Outcomes"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814315","article-title":"Treatment with the topical antimicrobial peptide omiganan in mild-to-moderate facial seborrheic dermatitis versus ketoconazole and placebo: results of a randomized controlled proof-of-concept trial","volume":"24","author":"Rousel J","year":"2023","unstructured":"Rousel J, Saghari M, Pagan L, et al.. Treatment with the topical antimicrobial peptide omiganan in mild-to-moderate facial seborrheic dermatitis versus ketoconazole and placebo: results of a randomized controlled proof-of-concept trial. Int J Mol Sci. 2023, 24:14315. 10.3390\/ijms241814315","journal-title":"Int J Mol Sci"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200405060-00006","article-title":"Role of antifungal agents in the treatment of seborrheic dermatitis","volume":"5","author":"Gupta AK","year":"2004","unstructured":"Gupta AK, Nicol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol. 2004, 5:417-22. 10.2165\/00128071-200405060-00006","journal-title":"Am J Clin Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278336-ocular-manifestations-in-seborrheic-dermatitis-epidemiology-clinical-features-and-management-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:06:14Z","timestamp":1727453174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278336-ocular-manifestations-in-seborrheic-dermatitis-epidemiology-clinical-features-and-management-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":111,"URL":"https:\/\/doi.org\/10.7759\/cureus.70335","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}